Sector portfolio · VC firm · United States
Deerfield's Biotech portfolio
Deerfield has backed 66 Biotech startups in rounds we track, $8.6B between them, shown by the stage each has reached. The best-funded is Abivax.
66startups backed
6stages
$8.6Braised between them
Stage not reportedbiggest stage
Abivax
Nuvalent
Valneva
TriNetX
Schrödinger
Ascend Advanced Therapies
Great Lakes Discoveries LLC- TPTris Pharam
Braeburn
Ribon Therapeutics
Pinnacle Hill
Ancora Innovation- PIPoseidon Innovation
Lakeside Discovery
Werewolf Therapeutics
Sollis
Blade Therapeutics- WWellfount
- CConcertoHealth
- TWThird Wave Technologies
- CMCystetic Medicines
Elutia
Series A
15
Series B
12
Funding by segment
- Stage not reported$3.2B22
- Series A$1.0B15
- Series C and later$2.2B13
- Series B$1.9B12
- Pre-seed and seed$43M2
- Growth$281M2
Where they are based
- United States56$5.9B
- France2$1.1B
- United Kingdom1$67M
- Switzerland1$646M
- Hong Kong SAR China1$392M
- Ireland1$207M
- Canada1$140M
United States
France
United Kingdom
Switzerland
Hong Kong SAR China
Ireland
CanadaFounded
13Earlier
212
713
14
615
316
517
418
219
320
321
322
123
24
25
26
14 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M0
- $10M to $50M19
- $50M to $250M37
- $250M to $1B9
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
52 of 66 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States56
- France2
- United Kingdom1
- Switzerland1
- Hong Kong SAR China1
- Ireland1
- Canada1
Startups by country, 7 countries in all.
Segment by segment
Stage not reported
22 startups · $3.2B raised
- AbivaxAbivax develops medicines that alter the body's natural immune system mechanisms.France$793M
- NuvalentNuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.United States$500M
- ValnevaValneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.France$310M
- TriNetXTriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.United States$240M
- SchrödingerSchrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotecUnited States$195M
- Ascend Advanced TherapiesAscend Advanced Therapies is a Contract Development and Manufacturing Organization (CDMO) that specializes in advanced therapies, United States$131M
- Great Lakes Discoveries LLCGreat Lakes Discoveries is a company set up by University of Michigan to boost drug commercialisation efforts.United States$130M
- TPTris PharamUnited States$125M
Series A
15 startups · $1.0B raised
Rhythm PharmaceuticalsRhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeuticsUnited States$311M
Bitterroot BioBitterroot Bio, Inc.United States$145M
OncorusOncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.United States$77M
Apertura Gene TherapyApertura Gene Therapy is a biotechnology company focused on developing advanced gene therapies for rare and genetic diseases.United Kingdom$67M
Vicinitas TherapeuticsVicinitas Therapeutics is a biotechnology company founded in 2022 and based in South San Francisco, California.United States$65M
AdelaAdela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.United States$65M
Civetta TherapeuticsCivetta Therapeutics was a biotechnology company based in Cambridge, Massachusetts, founded in 2019.United States$53M
Stelexis TherapeuticsStelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.United States$43M
Series C and later
13 startups · $2.2B raised
ADC TherapeuticsADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.Switzerland$646M- IMInsilico MedicineHong Kong SAR China$392M
LetsGetCheckedLetsGetChecked is a global virtual care and health diagnostics company founded in Dublin, Ireland, in 2014.Ireland$207M
MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
Kolltan PharmaceuticalsKolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.United States$146M
MedAvailMedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.Canada$140M
Strata OncologyStrata Oncology is a precision oncology company dedicated to transforming cancer care.United States$90M
Shockwave MedicalShockwave Medical is a medical device company that develops Intravascular Lithotripsy (IVL) for treating calcified coronary diseases.United States$88M
Series B
12 startups · $1.9B raised
Global Blood TherapeuticsGBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.United States$389M
Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
Acutus MedicalAcutus Medical develops medical technologies to treat complex cardiac arrhythmia.United States$268M- NNeomorphUnited States$209M
Voyager TherapeuticsVoyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.United States$205M
Generation BioGeneration Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.United States$176M
Conventus OrthopaedicsConventus Orthopaedics is a provider of a range of orthopedic and sports medicine services.United States$94M
Actio BiosciencesActio Biosciences is a research center that develops drugs for rare diseases.United States$66M
Pre-seed and seed
2 startups · $43M raised
- RRhythmUnited States$42M
UTR Therapeutics Inc.UTR Therapeutics Inc.United States$400K
Growth
2 startups · $281M raised
Epic SciencesEpic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.United States$165M
Hana BiosciencesTalon Therapeutics is a biopharmaceutical company develops and commercializes new and differentiated cancer therapies.United States$116M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Deerfield as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioDeerfield's Healthtech portfolio17 startups · $2.5BPortfolio mapDeerfield portfolio map99 startups · $13BCo-investorsWho invests with Deerfield62 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426B
Raising from investors like Deerfield?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.